KPP Advisory Services LLC Acquires 970 Shares of Zoetis Inc. (NYSE:ZTS)

KPP Advisory Services LLC lifted its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 17.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,646 shares of the company’s stock after purchasing an additional 970 shares during the period. KPP Advisory Services LLC’s holdings in Zoetis were worth $1,094,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Mission Wealth Management LP boosted its holdings in shares of Zoetis by 2.0% during the 4th quarter. Mission Wealth Management LP now owns 2,938 shares of the company’s stock worth $479,000 after buying an additional 59 shares in the last quarter. HUB Investment Partners LLC lifted its position in shares of Zoetis by 4.7% during the 4th quarter. HUB Investment Partners LLC now owns 1,373 shares of the company’s stock valued at $224,000 after acquiring an additional 62 shares during the period. Coppell Advisory Solutions LLC boosted its stake in Zoetis by 18.0% during the fourth quarter. Coppell Advisory Solutions LLC now owns 420 shares of the company’s stock worth $68,000 after acquiring an additional 64 shares in the last quarter. Lindbrook Capital LLC boosted its stake in Zoetis by 1.8% during the fourth quarter. Lindbrook Capital LLC now owns 3,650 shares of the company’s stock worth $595,000 after acquiring an additional 65 shares in the last quarter. Finally, Ironwood Investment Management LLC grew its holdings in Zoetis by 0.8% in the fourth quarter. Ironwood Investment Management LLC now owns 8,354 shares of the company’s stock worth $1,361,000 after purchasing an additional 68 shares during the period. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on ZTS shares. UBS Group dropped their price objective on shares of Zoetis from $189.00 to $170.00 and set a “neutral” rating on the stock in a report on Wednesday, May 7th. Piper Sandler upped their price target on Zoetis from $205.00 to $210.00 and gave the stock an “overweight” rating in a research note on Monday, May 12th. Stifel Nicolaus lowered Zoetis from a “buy” rating to a “hold” rating and cut their price target for the stock from $165.00 to $160.00 in a report on Wednesday, June 18th. Finally, Wall Street Zen upgraded Zoetis from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Two research analysts have rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $212.13.

Insider Buying and Selling at Zoetis

In other news, EVP Roxanne Lagano sold 652 shares of the business’s stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total value of $110,840.00. Following the transaction, the executive vice president now owns 15,129 shares in the company, valued at $2,571,930. The trade was a 4.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.18% of the company’s stock.

Zoetis Stock Performance

Shares of ZTS opened at $157.41 on Thursday. The firm has a market capitalization of $70.08 billion, a P/E ratio of 28.26, a P/E/G ratio of 2.62 and a beta of 0.94. Zoetis Inc. has a 52 week low of $139.70 and a 52 week high of $200.33. The stock has a 50 day moving average price of $160.10 and a two-hundred day moving average price of $163.02. The company has a debt-to-equity ratio of 1.12, a quick ratio of 1.04 and a current ratio of 1.74.

Zoetis (NYSE:ZTS) last announced its earnings results on Tuesday, May 6th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.08. The company had revenue of $2.22 billion for the quarter, compared to analysts’ expectations of $2.20 billion. Zoetis had a return on equity of 55.48% and a net margin of 27.12%. Zoetis’s quarterly revenue was up 1.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.38 earnings per share. Equities analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 3rd. Shareholders of record on Friday, July 18th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.27%. The ex-dividend date of this dividend is Friday, July 18th. Zoetis’s payout ratio is 35.91%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.